by Pill Pals | Mar 12, 2025 | News
Update | February 7, 2025The Drug Development Tool (DDT) Qualification Programs and ISTAND1 Pilot Program, have updated the program metrics to give the public and industry partners more clarity and transparency around our activities. In accordance with the 21st...
by Pill Pals | Mar 12, 2025 | News
Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Seunghyun Cho Recipient Title General Manager Natuzen Co., Ltd. 289 Namdongdong-RoNamdong-guIncheon21639South Korea Issuing Office: Center for Drug Evaluation and Research | CDER United States...
by Pill Pals | Mar 12, 2025 | News
Reference #: FEI 3006731547 Product: Drugs Recipient: Recipient Name Mr. Young-Gi Son Recipient Title President Natuzen Co., Ltd. 289 Namdongdong-RoNamdong-guIncheon21639South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary...
by Pill Pals | Mar 12, 2025 | News
Downloadable Data Files for the Orange Book The compressed (.ZIP) data file unzips into three files, whose field descriptions appear below. All three files are in ASCII text, tilde (~) delimited format. The Orange Book Appendices are available in PDF format:...
by Pill Pals | Mar 12, 2025 | News
Delivery Method: Return Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Yongjun Tu Recipient Title Chief Executive Officer and Chairman of the Board Zhejiang Tianyu Pharmaceutical Co., Ltd. Jiangkou Development ZoneHuangyan QuTaizhou ShiZhejiang Sheng,...
by Pill Pals | Mar 12, 2025 | News
Reference #: FEI 3010972581 Product: Drugs Recipient: Recipient Name Mr. Tu Yongjun Recipient Title President and Founder Zhejiang Tianyu Pharmaceutical Co Ltd Jiangkou Development ZoneHuangyan QuTaizhou ShiZhejiang Sheng, 318020China Issuing Office: Center for Drug...